Amgen Recalls Kyprolis Vials Due to Potential Glass Cracks
Amgen is recalling 11,434 vials of Kyprolis (carfilzomib) injection because potential cracks in the glass vials may compromise sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving significant injury/property-damage reports or structural defects (glass cracks compromising sterility) are rated Severe (4).
Plain-English summary
Amgen, Inc. is recalling 11,434 vials of Kyprolis (carfilzomib) for injection, 30 mg per vial. The recall is due to a lack of assurance of sterility caused by potential cracks in the glass vials.
The affected product is identified by Lot #1071559 and #1071629, with an expiration date of 05/18. The product was distributed in the United States and Puerto Rico. No foreign distribution occurred.
Healthcare providers and patients should stop using the affected vials and contact Amgen or their healthcare provider for further instructions.
The recalled product
- Product
- KYPROLIS (CARFILZOMIB)
- Brand
- KYPROLIS
- Manufacturer
- Amgen, Inc.
- Category
- Drug — Prescription Injection
- Hazard
- Affected units
- 11,434
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #1071559
- 1071629
- Exp. 05/18
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Amgen, Inc.
See all →- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29